Huang Yun-Shi, Chen Xiao-Dong, Shi Ming-Ming, Xu Li-Bin, Wang Su-Jun, Chen Wei-Sheng, Zhu Guan-Bao, Zhang Wei-Teng, Shen Xian
Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Department of Gastrointestinal Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Front Oncol. 2020 Jun 30;10:1050. doi: 10.3389/fonc.2020.01050. eCollection 2020.
The present study aimed to explore the association between spleen density and post-operative outcomes of patients after curative gastrectomy. From June 2014 to December 2015, we conducted a retrospective study to analyze pertinent clinical data from gastric cancer patients who underwent gastrectomy at the First and the Second Affiliated Hospital of Wenzhou Medical University. Spleen density was determined via computed tomography scans. Univariate and multivariate analyses were performed to determine the risk factors associated with post-operative outcomes after gastric cancer surgery. Three hundred and ninety five patients were included, of whom 98 (24.8%) were defined as having a diffuse reduction of spleen density based on diagnostic cutoff values (spleen density ≤43.89 HU). Multivariate analysis revealed diffuse reduction of spleen density as an independent risk factor for post-operative complications and long-term overall survival. Spleen density can predict severe postoperative complications and long-term overall survival in gastric cancer patients. As an imaging evaluation method, spleen density is a novel tool can be used in clinical as a prognostic predictor for patients with gastric cancer.
本研究旨在探讨根治性胃切除术后患者脾脏密度与术后结局之间的关联。2014年6月至2015年12月,我们进行了一项回顾性研究,以分析温州医科大学附属第一医院和第二医院接受胃切除术的胃癌患者的相关临床资料。通过计算机断层扫描确定脾脏密度。进行单因素和多因素分析以确定胃癌手术后与术后结局相关的危险因素。共纳入395例患者,其中98例(24.8%)根据诊断临界值(脾脏密度≤43.89 HU)被定义为脾脏密度弥漫性降低。多因素分析显示,脾脏密度弥漫性降低是术后并发症和长期总生存的独立危险因素。脾脏密度可预测胃癌患者术后严重并发症和长期总生存。作为一种影像学评估方法,脾脏密度是一种可在临床上用作胃癌患者预后预测指标的新型工具。